Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
187.27
+6.34 (3.50%)
Jan 14, 2026, 10:00 AM EST - Market open
Molina Healthcare Market Cap
Molina Healthcare has a market cap or net worth of $9.63 billion as of January 14, 2026. Its market cap has decreased by -42.99% in one year.
Market Cap
9.63B
Enterprise Value
8.93B
1-Year Change
-42.99%
Ranking
Category
Stock Price
$187.27
Market Cap Chart
Since July 2, 2003, Molina Healthcare's market cap has increased from $496.00M to $9.63B, an increase of 1,840.66%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 9.35B | 4.77% |
| Dec 31, 2025 | 8.92B | -46.42% |
| Dec 31, 2024 | 16.65B | -20.97% |
| Dec 29, 2023 | 21.06B | 9.23% |
| Dec 30, 2022 | 19.28B | 3.82% |
| Dec 31, 2021 | 18.58B | 47.29% |
| Dec 31, 2020 | 12.61B | 48.24% |
| Dec 31, 2019 | 8.51B | 17.34% |
| Dec 31, 2018 | 7.25B | 65.62% |
| Dec 29, 2017 | 4.38B | 42.00% |
| Dec 30, 2016 | 3.08B | -8.57% |
| Dec 31, 2015 | 3.37B | 30.17% |
| Dec 31, 2014 | 2.59B | 62.92% |
| Dec 31, 2013 | 1.59B | 26.16% |
| Dec 31, 2012 | 1.26B | 23.53% |
| Dec 30, 2011 | 1.02B | 21.16% |
| Dec 31, 2010 | 842.20M | 44.14% |
| Dec 31, 2009 | 584.30M | 23.22% |
| Dec 31, 2008 | 474.20M | -56.80% |
| Dec 31, 2007 | 1.10B | 20.27% |
| Dec 29, 2006 | 912.60M | 23.37% |
| Dec 30, 2005 | 739.70M | -42.04% |
| Dec 31, 2004 | 1.28B | 100.19% |
| Dec 31, 2003 | 637.50M | 28.53% |
| Jul 2, 2003 | 496.00M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |